Meeting
2021 ASCO Annual Meeting
Association of HER2 expression with pathologic features and prognosis in stage II and III colon cancer.
Authors
Zehua Wu
Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Zehua Wu , Huabin Hu , Yanhong Deng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Biologic Correlates
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3524)
DOI
10.1200/JCO.2021.39.15_suppl.3524
Abstract #
3524
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
First Author: Jean-François Flejou
Poster
2020 ASCO Virtual Scientific Program
Duration of FOLFOX adjuvant chemotherapy in high-risk stage II and stage III colon cancer with deficient DNA mismatch repair.
First Author: Zehua Wu
Poster
2019 ASCO Annual Meeting
Combination of tissues analysis and immune infiltrate in localized colon cancer using artificial intelligence in PETACC8 study.
First Author: Cynthia Reichling
Poster
2013 ASCO Annual Meeting
Prognostic impact of KRAS and BRAFV600E mutations stratified by tumor site in resected stage III colon cancer patients treated with adjuvant mFOLFOX6 with or without cetuximab: NCCTG N0147 (Alliance).
First Author: Frank A. Sinicrope